What is Atlanta Allergy & Asthma?
Founded in 1972, Atlanta Allergy & Asthma operates as a premier medical practice dedicated to the diagnosis and treatment of complex allergic, asthmatic, and immunological conditions. Headquartered in Kennesaw, Georgia, the organization distinguishes itself through a dual-focus model that integrates high-touch patient care with rigorous clinical research. By maintaining a robust network of facilities, the practice serves as a critical hub for patients seeking evidence-based interventions for chronic respiratory and immune-system disorders. Their market position is defined by decades of clinical expertise, allowing them to navigate the evolving regulatory and technological demands of the modern healthcare sector while maintaining a reputation for excellence in patient outcomes.
How much funding has Atlanta Allergy & Asthma raised?
Atlanta Allergy & Asthma has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Atlanta Allergy & Asthma
PPP
Public-Private Partnership
What's next for Atlanta Allergy & Asthma?
The infusion of capital marks a pivotal transition for Atlanta Allergy & Asthma as it moves toward a more integrated, enterprise-level operational framework. Future strategic priorities are expected to center on the modernization of diagnostic technologies and the expansion of clinical trial capabilities, which remain central to their value proposition. By leveraging this recent financial backing, the practice is well-positioned to enhance its digital health infrastructure and potentially broaden its geographic footprint. As the demand for specialized immunology services continues to rise, the organization is likely to focus on optimizing operational efficiencies and deepening its research partnerships to maintain its competitive edge in the Georgia healthcare market.
See full Atlanta Allergy & Asthma company page
